assessment of a Melissa extract capsule effects on lowering TG blood levels in diabetics

Not Applicable

• Conditions: type 2 diabetes mellitus.; Diabetes mellitus; E10, E11,

• Registration Number: IRCT2015112625251N1
• Lead Sponsor: Vice Chancellor for research, Shahid Sadoughei University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

inclusion criteria: diabetic patients aged 20y to 65y.; Hb A1C less than 8.5 %;
TG more than 150 mg in dl up to 500 mg in dl
exclusion criteria:any systemic disease; severe diabetic complication; neoplasia; psycologic diseases;pregnancy and lactation; smoking and addiction; any drug consumption with effects on lipid metabolism within the last month except of anti diabetic agents

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum TG. Timepoint: 0- 1m-2m-3m. Method of measurement: biochemical analysis.;HDL-LDL-Chol. Timepoint: 0- 1m-2m-3m. Method of measurement: biochemical analysis.;FBS. Timepoint: 0- 1m-2m-3m. Method of measurement: biochemical analysis.

Secondary Outcome Measures

Name	Time	Method
HbA1c. Timepoint: before-3m. Method of measurement: biochemical analysis.;AST-ALT-ALKP. Timepoint: before-3m. Method of measurement: biochemical analysis.;BUN-CRE. Timepoint: before-3m. Method of measurement: biochemical analysis.;Systolic & diastolic blood pressure. Timepoint: before-3m. Method of measurement: Sphygmomanometer.;BMI. Timepoint: before-3m. Method of measurement: formula.;Anthropometric measures. Timepoint: before-3m. Method of measurement: standardized meter.;Side effects. Timepoint: before-3m. Method of measurement: check list.